|
ARID5B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.32060000000734E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.848100E-02 |
| Normal-vs-Stage2 |
1.68060000005354E-06 |
| Normal-vs-Stage3 |
3.53510000050683E-07 |
| Normal-vs-Stage4 |
3.51960000033458E-08 |
| Stage1-vs-Stage2 |
2.020100E-04 |
| Stage1-vs-Stage3 |
1.88622999999222E-05 |
| Stage1-vs-Stage4 |
7.98229999987576E-07 |
| Stage2-vs-Stage3 |
8.672000E-01 |
| Stage2-vs-Stage4 |
4.983000E-01 |
| Stage3-vs-Stage4 |
3.284000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.355210E-04 |
| Normal-vs-AfricanAmerican |
1.588170E-04 |
| Normal-vs-Asian |
1.774020E-01 |
| Caucasian-vs-AfricanAmerican |
3.285400E-01 |
| Caucasian-vs-Asian |
9.808800E-01 |
| AfricanAmerican-vs-Asian |
6.412200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.28210000005513E-06 |
| Normal-vs-Female |
1.185710E-02 |
| Male-vs-Female |
8.957200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.452100E-02 |
| Normal-vs-Age(41-60Yrs) |
9.164100E-03 |
| Normal-vs-Age(61-80Yrs) |
4.11569999969608E-07 |
| Normal-vs-Age(81-100Yrs) |
1.43890000003921E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.112800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.576400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.237700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.725560E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.801370E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.635600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.980400E-01 |
| Normal-vs-Grade 2 |
8.521600E-02 |
| Normal-vs-Grade 3 |
1.76640000404404E-08 |
| Normal-vs-Grade 4 |
3.2206000089019E-09 |
| Grade 1-vs-Grade 2 |
4.784600E-01 |
| Grade 1-vs-Grade 3 |
6.458100E-03 |
| Grade 1-vs-Grade 4 |
1.062330E-02 |
| Grade 2-vs-Grade 3 |
3.45999999995517E-06 |
| Grade 2-vs-Grade 4 |
2.09860000488504E-08 |
| Grade 3-vs-Grade 4 |
5.924400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.787700E-02 |
| Normal-vs-ccB subtype |
1.025620E-04 |
| ccA subtype-vs-ccB subtype |
2.880300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.058110E-03 |
| Normal-vs-N1 |
1.139700E-03 |
| N0-vs-N1 |
1.278570E-01 |
|
|
